Re: Re: A VERY SAD DAY IN THE MOLD COMMUNITY

[Guest guest]

They have apparently just figured out (!) how a huge amount of sinusitis is

fungal, not bacterial, and needs to be treated with antifungals, which is

new information to the mainstream MDs I guess, but from what I have heard

here, its what Dr. Marinkovich sort of pioneered.

So that other guy seems now to have been wrong and much recent science

proves that Dr. Marinkovich's approach was a good one all along, and he had

the courage to stick with it even as they were giving him so much trouble.

(Perhaps some in the medical establishment have a bias against therapies

that address root causes of issues and don't get them into a cycle where

they have to keep paying to use some drug forever?)

> >I was asked recently by a local doctor... " How did you get hooked up

> with Dr. Marinkovich? " He said, " Don't you know those Mayo Clinic

> findings have been disproved? His fungal sprays don't work. " I said

> " Oh really? The intense facial pain I endured for years didn't

> disappear until I used his spray. Guess the proof is in the pudding. "

> What could he say in response? Handed me the latest pharmaceutical

> financial pursuit sample and sent me on my way.

>

>

[Guest guest]

Dear All,

I put this post on ToxLaw a couple of days ago. Decided to repost it here

because I thought that some of you may not be aware how long and in what great

detail Dr. Marinkovich's studies of hypsersensitivity pneumonitis brought on

by mold exposure are. I wanted you all to know that whether you were a

patient of Dr. Marinkovich or not, his work has made a positive impact on your

life. He has helped tremendously to change the perception of the seriousness of

mold induced illness. He has educated many physicians around the world. I am

sad he is no longer with us. But am grateful to be able to say he was my

friend. I learned so much from him, not only about the science but about the

political obsticles he fought so hard to overcome so that the sick could obtain

medical treatment.

The world has lost a great scholar and a true gentleman. Many of us were

fortunate enough to have our lives touched and our health improved by Dr.

Marinkovich. In the face of great adversity brought on by those more

concerned with money than the well being of their fellowman, he stood strong

in his support of the sick and his desire to ethically move the scientific

understanding of mold induced illnesses forward. Dr. Marinkovich was a model in

character of what a man of medicine should strive to be. He was dearly loved

and greatly respected by many. His personal presence and his presence in

medicine will be sorely missed. But no doubt, many will benefit from his work

for generations to come.

Below is taken from Dr. Marinkovich's Biographical Sketch, when he was a

presenter at a US Senate Staff Briefing in regard to mold and mold toxin

induced

illnesses, Washington DC, January 2006. The information that the Senate was

able to learn from this briefing was the catalyst that caused a Federal GAO

audit into the mold issue. The results of the investigation should be coming

soon. I only wish Dr. Marinkovich was here to see it. Along with Dr.

Marinkovich; Dr. Shoemaker, Dr. Yang and Dr. Sherris presented about the

illnesses

we are experiencing from indoor microbial contamination. The four men together

were able to make our nation's decision makers better understand we are sick

beyond simple allergy.

Biographical Sketch: A. Marinkovich

" Dr. Marinkovich received his Bachelor of Science degree in physics from the

California Institute of Technology in 1955 and his Doctor of Medicine degree

from Harvard Medical School in 1959. He completed his internship and

residency in pediatrics at s Hopkins Hospital in 1961. For the 1961-62

academic

year he received a Jane Coffin Childs award to study population genetics with

Professor Alan son at Oxford University, Oxford, England (6 months) and

biochemical genetics with professor Harry at King’s

College, London (6 months). He returned to Caltech in 1962 on an NIH

Fellowship to study immunology with Professor Ray Owen. He was appointed an

instructor in immunology at Caltech in 1964. In 1965, he was appointed

assistant

professor in the Department of Pediatrics at Stanford Medical School. He

received

clinical allergy training at Stanford and was appointed director of Allergy

and Immunology in the Pediatric Department at Stanford.

In 1968, he received a five-year Research Career Development Award from the

National Institutes of Health and received research funding from the NIH to

establish an immunology research laboratory at the Stanford Children’s

Hospital. In the academic year 1971-72, he took sabbatical leave to study

hypersensitivity lung diseases with Professor Jack Pepys at the Brompton

Cardiothoracic

Institute in London. He left his full time position at Stanford in 1973, but

continued to teach as a clinical assistant professor, later clinical

associate professor in Pediatrics. From 1973 to 1980, he split his time

half-and-half

between the private practice of allergy and research leading to the

development of a new technology for the simultaneous detection of IgE to a

multitude

of allergens from a single serum sample.

This technology is now used worldwide in diagnosing allergy and marketed by

Hitachi Chemical Diagnostics, Inc. In the subsequent years (1980 to 1999), his

research centered on food and mold hypersensitivity. In 1999 he and his

co-workers developed a new, very accurate technology for multiple allergenic

antibody (IgE) identification, using only 5 microliters of serum. This small

volume makes it possible for the first time, to use a fingerstick to obtain

sufficient blood to diagnose allergy. In 2002, the Food and Drug Administration

(FDA) cleared the test as an accurate measure of specific IgE antibody. In

2003, the FDA cleared the test for sale direct to consumers (OTC). "

Sharon Kramer

************************************** See what's new at http://www.aol.com

[Guest guest]

Aren't you pretty Sharon!! Thanks for sharing. Did Dr. M have a favorite

charity or foundation that maybe if others wanted to donate in his honor. If

you don't know could we find out?

a

tigerpaw2c <tigerpaw2c@...> wrote:

Just to let you know I thought it would be appropriate to start a

photo album in tribute of Dr.Marinkovich. I've added one picture

that we had when we visited him in 02. If any of you have any other

pictures please add them to the album.

Thank you kindly,

KC

>

>

> Dear All,

> I put this post on ToxLaw a couple of days ago. Decided to repost

it here

> because I thought that some of you may not be aware how long and

in what great

> detail Dr. Marinkovich's studies of hypsersensitivity pneumonitis

brought on

> by mold exposure are. I wanted you all to know that whether you

were a

> patient of Dr. Marinkovich or not, his work has made a positive

impact on your

> life. He has helped tremendously to change the perception of the

seriousness of

> mold induced illness. He has educated many physicians around the

world. I am

> sad he is no longer with us. But am grateful to be able to say

he was my

> friend. I learned so much from him, not only about the science

but about the

> political obsticles he fought so hard to overcome so that the

sick could obtain

> medical treatment.

> The world has lost a great scholar and a true gentleman. Many of

us were

> fortunate enough to have our lives touched and our health improved

by Dr.

> Marinkovich. In the face of great adversity brought on by those

more

> concerned with money than the well being of their fellowman, he

stood strong

> in his support of the sick and his desire to ethically move the

scientific

> understanding of mold induced illnesses forward. Dr. Marinkovich

was a model in

> character of what a man of medicine should strive to be. He was

dearly loved

> and greatly respected by many. His personal presence and his

presence in

> medicine will be sorely missed. But no doubt, many will benefit

from his work

> for generations to come.

> Below is taken from Dr. Marinkovich's Biographical Sketch, when he

was a

> presenter at a US Senate Staff Briefing in regard to mold and

mold toxin induced

> illnesses, Washington DC, January 2006. The information that the

Senate was

> able to learn from this briefing was the catalyst that caused a

Federal GAO

> audit into the mold issue. The results of the investigation

should be coming

> soon. I only wish Dr. Marinkovich was here to see it. Along with

Dr.

> Marinkovich; Dr. Shoemaker, Dr. Yang and Dr. Sherris presented

about the illnesses

> we are experiencing from indoor microbial contamination. The four

men together

> were able to make our nation's decision makers better understand

we are sick

> beyond simple allergy.

> Biographical Sketch: A. Marinkovich

> " Dr. Marinkovich received his Bachelor of Science degree in

physics from the

> California Institute of Technology in 1955 and his Doctor of

Medicine degree

> from Harvard Medical School in 1959. He completed his internship

and

> residency in pediatrics at s Hopkins Hospital in 1961. For

the 1961-62 academic

> year he received a Jane Coffin Childs award to study population

genetics with

> Professor Alan son at Oxford University, Oxford, England (6

months) and

> biochemical genetics with professor Harry at King’s

> College, London (6 months). He returned to Caltech in 1962 on an

NIH

> Fellowship to study immunology with Professor Ray Owen. He was

appointed an

> instructor in immunology at Caltech in 1964. In 1965, he was

appointed assistant

> professor in the Department of Pediatrics at Stanford Medical

School. He received

> clinical allergy training at Stanford and was appointed director

of Allergy

> and Immunology in the Pediatric Department at Stanford.

> In 1968, he received a five-year Research Career Development Award

from the

> National Institutes of Health and received research funding from

the NIH to

> establish an immunology research laboratory at the Stanford

Children’s

> Hospital. In the academic year 1971-72, he took sabbatical leave

to study

> hypersensitivity lung diseases with Professor Jack Pepys at the

Brompton Cardiothoracic

> Institute in London. He left his full time position at Stanford

in 1973, but

> continued to teach as a clinical assistant professor, later

clinical

> associate professor in Pediatrics. From 1973 to 1980, he split

his time half-and-half

> between the private practice of allergy and research leading to

the

> development of a new technology for the simultaneous detection of

IgE to a multitude

> of allergens from a single serum sample.

> This technology is now used worldwide in diagnosing allergy and

marketed by

> Hitachi Chemical Diagnostics, Inc. In the subsequent years (1980

to 1999), his

> research centered on food and mold hypersensitivity. In 1999 he

and his

> co-workers developed a new, very accurate technology for multiple

allergenic

> antibody (IgE) identification, using only 5 microliters of serum.

This small

> volume makes it possible for the first time, to use a fingerstick

to obtain

> sufficient blood to diagnose allergy. In 2002, the Food and Drug

Administration

> (FDA) cleared the test as an accurate measure of specific IgE

antibody. In

> 2003, the FDA cleared the test for sale direct to consumers

(OTC). "

> Sharon Kramer

>

>

>

> ************************************** See what's new at

http://www.aol.com

>

>

>